Literature DB >> 27468879

The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients.

M Plesko, J Suvada, M Makohusova, I Waczulikova, D Behulova, A Vasilenkova, M Vargova, A Stecova, E Kaiserova, A Kolenova.   

Abstract

Bacterial infection is the most common complication in paediatric oncological patients during cancer treatment. A suitable tool for early prediction of unfavourable course of infection is still needed. We performed a prospective longitudinal observational study to evaluate of the role of serum biomarkers (C-reactive protein, procalcitonin, interleukin-6, presepsin) in the early diagnosis of bacteraemia (gram-negative versus gram-positive) in patients with haematological malignancies. We observed 69 febrile episodes in 33 patients (17 male, 16 female; 1.5-18.9 years, mean 7.31 years, median 5 years). Within this sample, there were 22 cases of positive blood cultures, 16 cases of sepsis, 38 cases of fever with no signs or symptoms of sepsis, and two deaths from infectious complications. All markers tested had good negative predictive value (73% - 93%). CRP was characterized by good specificity for registration bacteraemia (96%, 95% CI: 85% - 99%), but other results were inconclusive. We identified comparably balanced sensitivity (64% - 81%) and specificity (61% - 88%) for interleukin-6 and procalcitonin, and we proved their quality to predict positive blood culture and clinical signs of sepsis as well. Patients with gram-negative bacteraemia had significantly elevated levels of PCT and IL-6 in comparison with a group of patients with gram-positive bacteraemia (p = 0.04 for PCT and p = 0.005 for IL-6). Presepsin was characterized by poor specificity (27%, 95% CI: 15% - 43%) and positive predictive value (24%, 95% CI: 12 - 39%) for predicting bacteraemia, and by better sensitivity (84%, 95% CI: 55% - 98%) and specificity (58%, 95% CI: 42% - 73%) for predicting clinical signs of sepsis.

Entities:  

Keywords:  C-reactive protein; fever; interleukin-6; presepsin; procalcitonin; sepsis.

Mesh:

Substances:

Year:  2016        PMID: 27468879     DOI: 10.4149/neo_2016_512

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  7 in total

1.  Development and validation of a prediction model for moderately severe and severe acute pancreatitis in pregnancy.

Authors:  Du-Jiang Yang; Hui-Min Lu; Yong Liu; Mao Li; Wei-Ming Hu; Zong-Guang Zhou
Journal:  World J Gastroenterol       Date:  2022-04-21       Impact factor: 5.374

2.  Time-resolved fluorescent immunoassay-based combined detection of procalcitonin, C-reactive protein, heparin binding protein, and serum amyloid A1 to improve the diagnostic accuracy of early infection.

Authors:  Tingting Niu; Yang Liu; Feifei Zhu; Jiayan Ma; Jimin Gao
Journal:  J Clin Lab Anal       Date:  2018-10-18       Impact factor: 2.352

3.  Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.

Authors:  Maria Papp; Tamas Tornai; Zsuzsanna Vitalis; Istvan Tornai; David Tornai; Tamas Dinya; Andrea Sumegi; Peter Antal-Szalmas
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

4.  Diagnostic Accuracy of Immunologic Biomarkers for Accurate Diagnosis of Bloodstream Infection in Patients with Malignancy: Procalcitonin in Comparison with C-Reactive Protein.

Authors:  Mansoureh Shokripour; Navid Omidifar; Kourosh Salami; Mohsen Moghadami; Babak Samizadeh
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-10-31       Impact factor: 2.471

5.  Is There a Role of Presepsin as a Novel Biomarker in Pediatric Sepsis?

Authors:  Daisy Khera; Nisha Toteja; Surjit Singh; Simranjeet Singh; Prawin Kumar; Praveen Sharma; Kuldeep Singh
Journal:  Indian J Crit Care Med       Date:  2022-06

6.  Selective biomarkers for inflammation and infection are associated with post-operative complications following transperineal template prostate biopsy (TTPB): a single-centre observational clinical pilot-study.

Authors:  Nana Yaa Frempomaa Snyper; Joanne Pike; Kingsley Ekwueme; Iqbal Shergill; Stephen Fôn Hughes
Journal:  Eur J Med Res       Date:  2022-09-26       Impact factor: 4.981

Review 7.  Differential Markers of Bacterial and Viral Infections in Children for Point-of-Care Testing.

Authors:  Yu-Ting Tsao; Yao-Hung Tsai; Wan-Ting Liao; Ching-Ju Shen; Ching-Fen Shen; Chao-Min Cheng
Journal:  Trends Mol Med       Date:  2020-09-29       Impact factor: 11.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.